Growth Equity
Bain Capital Double Impact
Bain Capital Double Impact takes minority stakes in growing companies, usually without full control, from United States. It states a focus on healthcare & life sciences, education and environmental & safety.
Stated investment criteria
What Bain Capital Double Impact says it buys
Read from Bain Capital Double Impact’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.
Sources
A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by Bain Capital Double Impact to consider any particular business, and nothing on this page is represented as being for sale.
SEC filings
What Bain Capital Double Impact has raised
From this firm's own Form D filings. A fund files one within fifteen days of its first sale, under penalty of perjury, which makes these the hardest numbers on the page.
| Vehicles filed | 3 |
| Total capital raised | $1.9bn |
| Largest single vehicle | $1.3bn |
| Filing history | 2016 to 2023 |
| Smallest accepted commitment | None stated |
| Filed from | MASSACHUSETTS |
Form D covers US-domiciled vehicles raised from accredited investors. It will not capture a fund raised outside the United States, separately managed accounts, or capital deployed off balance sheet, so treat these as a floor rather than a total.
Regulatory record
How Bain Capital Double Impact is registered
From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.
| Adviser status | SEC registered |
| Regulatory assets under management | $96bn |
| Employees | 919 |
| Private funds advised | 36 · $100bn gross |
| SEC adviser number | CRD 145653 |
Portfolio
Disclosed holdings
Companies Bain Capital Double Impact lists on its own website. 11 carry a stated investment year.
| Company | Invested | Years held | Recorded transaction |
|---|---|---|---|
| HealthDrive | 2019 | 7 | — |
| ConvenientMD | 2021 | 5 | — |
| Cotopaxi | 2021 | 5 | — |
| Japan Wind Development | 2021 | 5 | — |
| Lillio | 2021 | 5 | — |
| Living Earth | 2021 | 5 | — |
| athenahealth | 2021 | 5 | — |
| FreeWill | 2022 | 4 | — |
| Meteor Education | 2023 | 3 | — |
| Branching Minds | 2024 | 2 | — |
| Legacy Hospice | 2025 | 1 | — |
| AqueoUS | — | — | — |
| AqueoUS Vets | — | — | — |
| Arosa 2018 | — | — | — |
| Bain Capital InsuranceInsurance | — | — | — |
| Bain Capital Private EquityPrivate Equity | — | — | — |
| Basic Home Infusion 2022 | — | — | — |
| Beatnic 2018 | — | — | — |
| Branching Minds 2024 | — | — | — |
| Broadstep 2019 | — | — | — |
| ConvenientMD 2021 | — | — | — |
| Cotopaxi 2021 | — | — | — |
| Credit | — | — | — |
| FreeWill 2022 | — | — | — |
| HealthDrive 2019 | — | — | — |
| Impact Fitness 2016 | — | — | — |
| LOCATIONS | — | — | — |
| Legacy Hospice 2025 | — | — | — |
| Life Sciences | — | — | — |
| Lillio 2021 | — | — | — |
| Living Earth 2021 | — | — | — |
| Meteor Education 2023 | — | — | — |
| Pacha Soap Co 2021 | — | — | — |
| Penn Foster 2019 | — | — | — |
| Presence 2019 | — | — | — |
| Real Estate | — | — | — |
| Rodeo Dental 2019 | — | — | — |
| Sparq 2019 | — | — | — |
| Special Situations | — | — | — |
| Spring Works 2017 | — | — | — |
| Sustainable Restaurant Group 2018 | — | — | — |
| TeachTown 2020 | — | — | — |
| Tech Opportunities | — | — | — |
Compiled from Bain Capital Double Impact’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.
Valuation context
Transaction values in Healthcare & Life Sciences
What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.
The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Is this Bain Capital Double Impact?
Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.
Claim or correct this profileTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.
Comparable investors
Similar mandates
Other growth equity investors active in healthcare & life sciences.